Next-Generation Sequencing in Latin America
This report is an examination of the use of DNA sequencing systems in the Latin American region, based on a survey conducted in Fall 2013 by VA Consultadoros. The survey centered on instrumentation, with a goal of providing a complete count of next-generation sequencing (NGS) systems sold to customers in the major countries of Latin American.
For the healthcare industry, Latin America is a focus. The region went through its highest economic growth period in the last four decades during 2000-2010. This growth brought almost a third of the total population in the region into middle class status — with around 70 percent of these residing in Mexico, Brazil, and Argentina. This economic development has brought investment in these nation's healthcare systems, which in turn has increased the focus on high-end biotechnology instrument expenditures for diagnostics and clinical research.
Genomics studies product cycle with Next Generation Sequencing (NGS) technology in Latin America (LatAm) is in its exponential phase and industry growth is greater than the regional investment in Science and Technology (S&T) compared against the expenditure in S&T as a percentage of GDP. Because of that it is necessary to acquire more information regarding the business dynamics, products/applications segmentation and main purchase drivers.
The report contains the following information as part of its coverage:
Number of NGS systems installed by country:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook